Skip to main content
OpenTrials

Clinical trial condition

Meningococcal Disease

Explore clinical trials studying Meningococcal Disease. Study availability and eligibility vary by location and protocol.

57 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Meningococcal Disease trial results

Completed

Safety and Immunogenicity of Novartis Meningococcal B Vaccine Formulated With OMV Manufactured at Two Different Sites, in Healthy Adolescents Aged 11-17 Years

NCT01423084

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +13 more
Locations
  • Royal Children's Hospital Herston, Queensland, Australia
  • AusTrials Pty Ltd-Suites 6, 10 & 11, Peninsula Specialist Centre Kippa-Ring, Queensland, Australia
  • AusTrials Pty Ltd-Suite 5, Level 1, 14 Primrose Street Sherwood, Queensland, Australia
  • Women's and Children's Hospital, 72 King William Road North Adelaide, South Australia, Australia
View all 13 locations
View Trial Details
Completed

Persistence of Antibody Levels and Response to Fifth or Third Meningococcal B Recombinant Vaccine in 4-year Old Healthy Children Who Previously Participated in Study V72P12E1

NCT01717638

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +13 more
Locations
  • Ordinace praktickeho lekare pro deti a dorost Jaroměř, Alšova 466, Czechia
  • Ordinace praktickeho lekare pro deti a dorost Jaroměř, Dr. E.Beneše 191, Czechia
  • Ordinace praktickeho lekare pro deti a dorost Sezemice, Havlickova 168, Czechia
  • Ordinace praktickeho lekare pro deti a dorost Hronov, Hostovského 485, Czechia
View all 29 locations
View Trial Details
Completed

Safety, Tolerability and Immunogenicity of a Third Dose of One of Four Different Formulations of rMenB + MenACWY Combination Vaccine in Adolescents Who Previously Received the Same Study Vaccines

NCT01367158

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +13 more
Locations
  • CESFAM Gabriela Mistral: Aurora de Chile 9872 - San Ramón, Saniago, Chile
  • Pontificia Universidad Catolica de Chile Marcoleta 350, Santiago Metropolitan, Chile
  • CAFAM Avenida Carrera 68# 90-88 Piso 4, Bogota D.C., Colombia
  • Centro de Investigacion CafeSalud Medicina Prepagada Carrera 14 No. 94-49 PisoSexto, Bogota D.C., Colombia
View Trial Details
Completed

Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of a Booster Dose of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received Three Doses of the Same Vaccine

NCT01026974

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Oxford Vaccine Group, Center for Clinical Vaccinology and Tropical Medicine, Churchill Hospital Oxford, United Kingdom
View Trial Details
Completed

Persistence of Immunogenicity of MenACWY Conjugate Vaccine 5 Years After Childhood Vaccination, and Immune Response to a Booster Dose

NCT01823536

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations
  • 82 Children s Inv Research Prgm (ChIRP) 2900 Medical Center Parkway, Ste. 300 Bentonville, Arkansas, United States
  • 83 AR Pediatric Clinical Research 500 South University, Ste. 200 Little Rock, Arkansas, United States
  • 32 Prem Health Research Center 9317 Firestone Blvd. Downey, California, United States
  • 27 KY Pediatric Adult Research 201 South 5th Street, Suite 102 Bardstown, Kentucky, United States
View all 16 locations
View Trial Details

Related conditions